Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy

Brain

Volumn 134, Issue 5, 2011, Pages 1277-1292

  Yu, Wen Ru ^a   Liu, Tianyi ^a   Kiehl, Tim Rasmus ^a,b   Fehlings, Michael G ^a,c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

cervical spondylotic myelopathy; Fas mediated apoptosis; inflammation

Indexed keywords

FAS ANTIBODY;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOPSY; CELL ACTIVATION; CELL DEATH; CERVICAL SPONDYLOTIC MYELOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MALE; MICROGLIA; MOUSE; NERVE CELL DEGENERATION; NERVE FIBER; NERVE REGENERATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCAR FORMATION; SPINAL CORD COMPRESSION; SPINAL CORD DISEASE; SPINAL CORD INJURY;

EID: 79957474401     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr054     Document Type: Article

References (55)

1. Ackery A, Robins S, Fehlings MG. Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 2006; 23: 604-16. (Pubitemid 43728050)
2. Akuzawa S, Kazui T, Shi E, Yamashita K, Bashar AH, Terada H. Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits. J Vasc Surg 2008; 48: 694-700.
3. Badie B, Schartner J, Vorpahl J, Preston K. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro. Exp Neurol 2000; 162: 290-6. (Pubitemid 30217724)
4. Becher B, Barker PA, Owens T, Antel JP. CD95-CD95L: Can the brain learn from the immune system? Trends Neurosci 1998; 21: 114-7. (Pubitemid 28080673)
5. Bohlman HH, Emery SE. The pathophysiology of cervical spondylosis and myelopathy. Spine 1988; 13: 843-6.
6. Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, et al. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury. BMC Neurol 2007; 7: 17.
7. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999; 19: 3248-57. (Pubitemid 29174016)
8. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001; 103: 203-18. (Pubitemid 32304360)
9. Casha S, Yu WR, Fehlings MG. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 2005; 196: 390-400. (Pubitemid 41607828)
10. Choi K, Benveniste EN, Choi C. Induction of intercellular adhesion molecule-1 by Fas ligation: Proinflammatory roles of Fas in human astroglioma cells. Neurosci Lett 2003; 352: 21-4. (Pubitemid 37412316)
11. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002; 158: 507-17. (Pubitemid 34851709)
12. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-6. (Pubitemid 27019144)
13. de Medinaceli L, Freed WJ, Wyatt RJ. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 1982; 77: 634-43. (Pubitemid 12011176)
14. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, et al. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 2004; 10: 389-95. (Pubitemid 38508517)
15. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 2003; 5: 118-25. (Pubitemid 36204194)
16. Emery E, Aldana P, Bunge MB, Puckett W, Srinivasan A, Keane RW, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998; 89: 911-20. (Pubitemid 28544043)
17. Fehlings MG, Skaf G. A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury. Spine 1998; 23: 2730-7. (Pubitemid 29013985)
18. Felderhoff-Mueser U, Taylor DL, Greenwood K, Kozma M, Stibenz D, Joashi UC, et al. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol 2000; 10: 17-29. (Pubitemid 30056390)
19. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, et al. The cellular inflammatory response in human spinal cords after injury. Brain 2006; 129: 3249-69. (Pubitemid 44871440)
20. Giulian D, Corpuz M. Microglial secretion products and their impact on the nervous system. Adv Neurol 1993; 59: 315-20.
21. Goussev S, Hsu JY, Lin Y, Tjoa T, Maida N, Werb Z, et al. Differential temporal expression of matrix metalloproteinases after spinal cord injury: Relationship to revascularization and wound healing. J Neurosurg 2003; 99: 188-97.
22. Hamada Y, Ikata T, Katoh S, Nakauchi K, Niwa M, Kawai Y, et al. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J Neurochem 1996; 66: 1525-31. (Pubitemid 26090555)
23. Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003; 41: 369-78. (Pubitemid 36819586)
24. Herx LM, Rivest S, Yong VW. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol 2000; 165: 2232-9. (Pubitemid 30643173)
25. Jones TB, Hart RP, Popovich PG. Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J Neurosci 2005; 25: 6576-83. (Pubitemid 40995289)
26. Keane RW, Kraydieh S, Lotocki G, Bethea JR, Krajewski S, Reed JC, et al. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 2001; 60: 422-9. (Pubitemid 32467099)
27. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M. Neuroprotective autoimmunity: Naturally occurring CD4 + CD25 + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA 2002; 99: 15620-5. (Pubitemid 35403981)
28. Letellier E, Kumar S, Sancho-Martinez I, Krauth S, Funke-Kaiser A, Laudenklos S, et al. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 2010; 32: 240-52.
29. Li GL, Brodin G, Farooque M, Funa K, Holtz A, Wang WL, et al. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord. J Neuropathol Exp Neurol 1996; 55: 280-9. (Pubitemid 26085577)
30. Li GL, Farooque M, Holtz A, Olsson Y. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol 1999; 98: 473-80. (Pubitemid 29476166)
31. Lou J, Lenke LG, Ludwig FJ, O'Brian MF. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 1998; 36: 683-90. (Pubitemid 28479074)
32. Mabon PJ, Weaver LC, Dekaban GA. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: A potential new anti-inflammatory treatment. Exp Neurol 2000; 166: 52-64.
33. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, et al. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 2001; 8: 679-86. (Pubitemid 32685165)
34. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, et al. CD95 ligand (Fas-L/APO-1 L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999; 19: 3809-17. (Pubitemid 29222257)
35. McCormack BM, Weinstein PR. Cervical spondylosis. An update. West J Med 1996; 165: 43-51.
36. McTigue DM, Tani M, Krivacic K, Chernosky A, Kelner GS, Maciejewski D, et al. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res 1998; 53: 368-76. (Pubitemid 28350400)
37. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, et al. Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity. J Autoimmun 2000; 15: 331-45.
38. Nakamura I, Ikegawa S, Okawa A, Okuda S, Koshizuka Y, Kawaguchi H, et al. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet 1999; 104: 492-7. (Pubitemid 29370925)
39. O'Connell J, Houston A, Bennett MW, O'Sullivan GC, Shanahan F. Immune privilege or inflammation? Insights into the Fas ligand enigma. Nat Med 2001; 7: 271-4. (Pubitemid 32224332)
40. Ohwada T, Ohkouchi T, Yamamoto T, Ono K. [Symptoms and pathological anatomy of the degenerative cervical spine]. Orthopade 1996; 25: 496-504.
41. Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, et al. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 2004; 76: 265-76. (Pubitemid 38451214)
42. Pallier PN, Drew CJ, Morton AJ. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: Influence of non-motor factors on locomotor function. Brain Res Bull 2009; 78: 347-55.
43. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 1999; 158: 351-65. (Pubitemid 29382826)
44. Popovich PG, Wei P, Stokes BT. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 1997; 377: 443-64. (Pubitemid 27016650)
45. Pouly S, Becher B, Blain M, Antel JP. Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol 2000; 59: 280-6. (Pubitemid 30183695)
46. Schwartz M, Kipnis J. Model of acute injury to study neuroprotection. Methods Mol Biol 2007; 399: 41-53.
47. Spanaus KS, Schlapbach R, Fontana A. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 1998; 28: 4398-408. (Pubitemid 28558671)
48. Springer JE, Azbill RD, Knapp PE. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 1999; 5: 943-6. (Pubitemid 29372423)
49. Swagerty DL Jr. Cervical spondylotic myelopathy: A cause of gait disturbance and falls in the elderly. Kans Med 1994; 95: 226-7, 229.
50. Uchida K, Baba H, Maezawa Y, Furukawa S, Furusawa N, Imura S. Histological investigation of spinal cord lesions in the spinal hyperostotic mouse (twy/twy): Morphological changes in anterior horn cells and immunoreactivity to neurotropic factors. J Neurol 1998; 245: 781-93. (Pubitemid 28505273)
51. Yamaura I, Yone K, Nakahara S, Nagamine T, Baba H, Uchida K, et al. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine 2002; 27: 21-6. (Pubitemid 34219521)
52. Yoshino O, Matsuno H, Nakamura H, Yudoh K, Abe Y, Sawai T, et al. The role of Fas-mediated apoptosis after traumatic spinal cord injury. Spine 2004; 29: 1394-404. (Pubitemid 38879042)
53. Yu WR, Baptiste DC, Liu T, Odrobina E, Stanisz GJ, Fehlings MG. Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: Implications for the pathophysiology of human cervical spondylotic myelopathy. Neurobiol Dis 2009a; 33: 149-63.
54. Yu WR, Liu T, Fehlings TK, Fehlings MG. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur J Neurosci 2009b; 29: 114-31.
55. Zurita M, Vaquero J, Zurita I. Presence and significance of CD-95 (Fas/APO1) expression after spinal cord injury. J Neurosurg 2001; 94: 257-64. (Pubitemid 32786053)